Copyright Reports & Markets. All rights reserved.

Global Topical Contraceptive Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Topical Contraceptive Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Topical Contraceptive Market Size Growth Rate by Product
      • 1.4.2 Topical Contraceptive Suppository
      • 1.4.3 Topical Contraceptive Film
      • 1.4.4 Topical Contraceptive Pill
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Topical Contraceptive Market Size Growth Rate by End User
      • 1.5.2 Online Stores
      • 1.5.3 Retail Stores
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Topical Contraceptive Market Size
      • 2.1.1 Global Topical Contraceptive Revenue 2014-2025
      • 2.1.2 Global Topical Contraceptive Sales 2014-2025
    • 2.2 Topical Contraceptive Growth Rate by Regions
      • 2.2.1 Global Topical Contraceptive Sales by Regions
      • 2.2.2 Global Topical Contraceptive Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Topical Contraceptive Sales by Manufacturers
      • 3.1.1 Topical Contraceptive Sales by Manufacturers
      • 3.1.2 Topical Contraceptive Sales Market Share by Manufacturers
      • 3.1.3 Global Topical Contraceptive Market Concentration Ratio (CR5 and HHI)
    • 3.2 Topical Contraceptive Revenue by Manufacturers
      • 3.2.1 Topical Contraceptive Revenue by Manufacturers (2014-2019)
      • 3.2.2 Topical Contraceptive Revenue Share by Manufacturers (2014-2019)
    • 3.3 Topical Contraceptive Price by Manufacturers
    • 3.4 Topical Contraceptive Manufacturing Base Distribution, Product Types
      • 3.4.1 Topical Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Topical Contraceptive Product Type
      • 3.4.3 Date of International Manufacturers Enter into Topical Contraceptive Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Topical Contraceptive Sales by Product
    • 4.2 Global Topical Contraceptive Revenue by Product
    • 4.3 Topical Contraceptive Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Topical Contraceptive Breakdown Data by End User

    6 North America

    • 6.1 North America Topical Contraceptive by Countries
      • 6.1.1 North America Topical Contraceptive Sales by Countries
      • 6.1.2 North America Topical Contraceptive Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Topical Contraceptive by Product
    • 6.3 North America Topical Contraceptive by End User

    7 Europe

    • 7.1 Europe Topical Contraceptive by Countries
      • 7.1.1 Europe Topical Contraceptive Sales by Countries
      • 7.1.2 Europe Topical Contraceptive Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Topical Contraceptive by Product
    • 7.3 Europe Topical Contraceptive by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Topical Contraceptive by Countries
      • 8.1.1 Asia Pacific Topical Contraceptive Sales by Countries
      • 8.1.2 Asia Pacific Topical Contraceptive Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Topical Contraceptive by Product
    • 8.3 Asia Pacific Topical Contraceptive by End User

    9 Central & South America

    • 9.1 Central & South America Topical Contraceptive by Countries
      • 9.1.1 Central & South America Topical Contraceptive Sales by Countries
      • 9.1.2 Central & South America Topical Contraceptive Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Topical Contraceptive by Product
    • 9.3 Central & South America Topical Contraceptive by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Topical Contraceptive by Countries
      • 10.1.1 Middle East and Africa Topical Contraceptive Sales by Countries
      • 10.1.2 Middle East and Africa Topical Contraceptive Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Topical Contraceptive by Product
    • 10.3 Middle East and Africa Topical Contraceptive by End User

    11 Company Profiles

    • 11.1 Allergan
      • 11.1.1 Allergan Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Allergan Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Allergan Topical Contraceptive Products Offered
      • 11.1.5 Allergan Recent Development
    • 11.2 Okamoto Industries
      • 11.2.1 Okamoto Industries Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Okamoto Industries Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Okamoto Industries Topical Contraceptive Products Offered
      • 11.2.5 Okamoto Industries Recent Development
    • 11.3 Reckitt Benckiser
      • 11.3.1 Reckitt Benckiser Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Reckitt Benckiser Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Reckitt Benckiser Topical Contraceptive Products Offered
      • 11.3.5 Reckitt Benckiser Recent Development
    • 11.4 Agile Therapeutics
      • 11.4.1 Agile Therapeutics Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Agile Therapeutics Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Agile Therapeutics Topical Contraceptive Products Offered
      • 11.4.5 Agile Therapeutics Recent Development
    • 11.5 Bayer Pharma
      • 11.5.1 Bayer Pharma Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Bayer Pharma Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Bayer Pharma Topical Contraceptive Products Offered
      • 11.5.5 Bayer Pharma Recent Development
    • 11.6 Ferring Pharmaceuticals
      • 11.6.1 Ferring Pharmaceuticals Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Ferring Pharmaceuticals Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Ferring Pharmaceuticals Topical Contraceptive Products Offered
      • 11.6.5 Ferring Pharmaceuticals Recent Development
    • 11.7 HLL Lifecare
      • 11.7.1 HLL Lifecare Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 HLL Lifecare Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 HLL Lifecare Topical Contraceptive Products Offered
      • 11.7.5 HLL Lifecare Recent Development
    • 11.8 Lupin Pharmaceuticals
      • 11.8.1 Lupin Pharmaceuticals Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Lupin Pharmaceuticals Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Lupin Pharmaceuticals Topical Contraceptive Products Offered
      • 11.8.5 Lupin Pharmaceuticals Recent Development
    • 11.9 Mayer Laboratories
      • 11.9.1 Mayer Laboratories Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Mayer Laboratories Topical Contraceptive Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Mayer Laboratories Topical Contraceptive Products Offered
      • 11.9.5 Mayer Laboratories Recent Development

    12 Future Forecast

    • 12.1 Topical Contraceptive Market Forecast by Regions
      • 12.1.1 Global Topical Contraceptive Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Topical Contraceptive Revenue Forecast by Regions 2019-2025
    • 12.2 Topical Contraceptive Market Forecast by Product
      • 12.2.1 Global Topical Contraceptive Sales Forecast by Product 2019-2025
      • 12.2.2 Global Topical Contraceptive Revenue Forecast by Product 2019-2025
    • 12.3 Topical Contraceptive Market Forecast by End User
    • 12.4 North America Topical Contraceptive Forecast
    • 12.5 Europe Topical Contraceptive Forecast
    • 12.6 Asia Pacific Topical Contraceptive Forecast
    • 12.7 Central & South America Topical Contraceptive Forecast
    • 12.8 Middle East and Africa Topical Contraceptive Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Topical Contraceptive Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Contraception is deliberate prevention of pregnancy by interfering with normal process of ovulation, fertilization and implantation through the use of barriers, drugs, medical devices or surgical techniques. Contraceptives are the drugs or devices which prevents pregnancy and sexually transmitted diseases (STDs).
      One trend in the market is increasing demand for other contraceptive methods. Other contraceptive methods are becoming more popular among women than topical contraceptives. This is because of the increased advantages provided by them. For instance, the demand for IUD, sterilization, female condoms, and oral pills is increasing.
      One driver in the market is proliferation of strategic initiatives. Innovation and effectiveness of female contraceptives are the key to market growth. Several vendors are entering into strategic alliances and investing in R&D for product innovation and better financial stability, thereby developing the latest products with better efficiency, safety, and protection.
      The Americas is estimated to be the major revenue contributor to the market by 2023. The market is expected to grow at an increased rate due to the increase in family planning initiatives undertaken by governments and non-governmental organizations (NGOs) in these countries. Additionally, the increase in awareness about the importance of contraceptives, their availability, and the affordability by teenagers, will also fuel the growth of the topical contraceptive market in this region.
      The global Topical Contraceptive market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Topical Contraceptive market based on company, product type, end user and key regions.

      This report studies the global market size of Topical Contraceptive in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Topical Contraceptive in these regions.
      This research report categorizes the global Topical Contraceptive market by top players/brands, region, type and end user. This report also studies the global Topical Contraceptive market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Allergan
      Okamoto Industries
      Reckitt Benckiser
      Agile Therapeutics
      Bayer Pharma
      Ferring Pharmaceuticals
      HLL Lifecare
      Lupin Pharmaceuticals
      Mayer Laboratories

      Market size by Product
      Topical Contraceptive Suppository
      Topical Contraceptive Film
      Topical Contraceptive Pill
      Others
      Market size by End User
      Online Stores
      Retail Stores

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Topical Contraceptive market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Topical Contraceptive market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Topical Contraceptive companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Topical Contraceptive submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Topical Contraceptive are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Topical Contraceptive market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now